From oral tablets like semaglutide and orforglipron to injectables like Retatrutide and CagriSema, these drugs provide diverse solutions for weight management
To compare, the companys own therapy Tirzepatide marketed as Mounjaro and Zepbound demonstrated an average loss of 20.9% of body weight in trial participants at 72 weeks
SKU / UPC Barcode: 610452802406
Audio editing was performed by CardioNerds Intern student Dr
A research article in the Two studies on the potential benefits of the GLP-1 receptor agonist tirzepatide were presented at the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit in Montreal in April
[1] The honest summary is that the animal record is heterogeneous: some biomarkers move favorably in some strains and protocols, but a clean, reproducible, cross-laboratory lifespan-extension signal is not established, and the variability across experiments is itself a reason for caution rather than a footnote to be skipped